# Assessment of Flow With the New Four-dimensional Velocity-encoded Magnetic Resonance Imaging Technique

Study · id `cardio:ct-nct02952287` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02952287](<https://clinicaltrials.gov/study/NCT02952287>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02952287

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02952287. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-11 (registry gives no type); primary completion 2021-08-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02952287, source copy `cardio:ctgov-nct02952287-2021-08-27`, retrieved 2026-10-26)
- Start date: 2016-11 (registry gives no type) (ClinicalTrials.gov record NCT02952287, source copy `cardio:ctgov-nct02952287-2021-08-27`, retrieved 2026-10-26)
- Primary completion: 2021-08-20 (actual) (ClinicalTrials.gov record NCT02952287, source copy `cardio:ctgov-nct02952287-2021-08-27`, retrieved 2026-10-26)
- Completion: 2021-08-20 (actual) (ClinicalTrials.gov record NCT02952287, source copy `cardio:ctgov-nct02952287-2021-08-27`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02952287-2021-08-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of Flow With the New Four-dimensional Velocity-encoded Magnetic Resonance Imaging Technique
- Acronym: 4D Flow
- Condition: Congenital Heart Disease (CHD)
- Intervention (Device): 4D PC MRI acquisition
- Lead sponsor: The Hospital for Sick Children
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: The Hospital for Sick Children (`cardio:org-the-hospital-for-sick-children`)

## Provenance

Content hash: a49bdfc17065c33010c51d3e058aecf9372340f5e2b5c63317e7db70411de819
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
